SPHRY

Starpharma Holdings Limited
OTC Markets OTCQXUSDEQUITY DELAYED
Last price
5.40
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
5.40
Day high
5.40
Day low
5.40
Volume
100
Market cap
P/E (TTM)
52W range
0.73 – 5.70

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.85% +4.9%
1M
+22.45% +19.0%
3M
+17.90% +15.4%
6M
+50.00% +38.0%
YTD
+122.22% +110.2%
1Y
+480.65% +460.4%
3Y
+395.41% +320.3%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on SPHRY open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 1 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $4.91M$8.29M$2.94M$4.68M -40.7%
Operating revenue $4.91M$8.29M$2.94M$4.68M -40.7%
Cost of revenue $1.22M$632.00K$1.12M$2.78M +93.7%
Gross profit $3.69M$7.66M$1.82M$1.91M -51.8%
Research & development $8.36M$10.05M$11.24M$11.68M -16.9%
Selling, general & admin $3.03M$3.57M$3.77M$3.29M -15.1%
Total operating expense $15.69M$18.40M$20.05M$19.62M -14.8%
Operating income -$12.00M-$10.75M-$18.24M-$17.71M -11.6%
Net interest income $938.00K$1.47M$1.27M$217.00K -36.1%
Pre-tax income -$9.99M-$8.16M-$15.64M-$16.15M -22.4%
Tax provision $0$0$0$0
Net income -$9.99M-$8.16M-$15.64M-$16.15M -22.4%
Net income to common -$9.99M-$8.16M-$15.64M-$16.15M -22.4%
Basic EPS -0.24-0.20-0.40-0.40 -19.5%
Diluted EPS -0.24-0.20-0.40-0.40 -19.5%
EBIT -$12.00M-$10.75M-$18.24M-$17.71M -11.6%
EBITDA -$10.93M-$9.63M-$17.04M-$16.63M -13.5%
Basic shares 41.72M41.14M40.90M40.69M +1.4%
Diluted shares 41.72M41.14M40.90M40.69M +1.4%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
5.29
+1.98% from price
SMA 20
5.09
+6.14% from price
SMA 50
4.85
+11.23% from price
SMA 100
4.77
+13.25% from price
SMA 200
3.76
+43.56% from price
EMA 12
5.21
+3.65% from price
EMA 26
5.07
+6.58% from price
EMA 50
4.92
+9.72% from price
RSI (14)
61.6
Neutral
MACD (12,26,9)
0.14
Hist 0.01
ATR (14)
0.18
3.24% of price
Realised vol 30D
61.9%
Annualised
Bollinger upper
5.66
20, 2σ
Bollinger lower
4.52
20, 2σ
50 / 200 cross
Golden
4.85 vs 3.76
Trend bias
Above 200
+43.56%

Options chain

Account required
Expiry
Spot 5.40
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.39
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
61.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-23.1%
Peak to trough
Max drawdown 5Y
-95.5%
Peak to trough
ATR 14
0.18
3.24% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.